Oncology Xagena
Daiichi Sankyo has announced the results of a prespecified subgroup analysis of 771 cancer patients enrolled in the phase 3 Hokusai-VTE study. Patients with either a history of cancer or with active c ...
Anticoagulation - For patients with active cancer, low-molecular-weight Heparin monotherapy without the transition to oral anticoagulation is preferred over Warfarin ( Coumadin ) by evidence-based gui ...
The efficacy and safety of Dabigatran ( Pradaxa ) for treatment of venous thromboembolism ( VTE ) were demonstrated in two trials. It is unclear if the results pertain to patients with cancer and veno ...
The objective of the study was to maintain living, interactive evidence ( LIvE ) on the benefits and harms of different treatment options in adults with cancer-associated thrombosis ( CAT ). Resear ...
